Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsLi Zhu, Adrian V. Lee, Jessica L. Narloch et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 125
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H. Strand, Graham A. Colditz, Belén Rivero‐Gutiérrez et al.|Cancer Cell|2022Cited by 88
Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspiratesDaniel Y. Joh, Ashutosh Chilkoti, Jacob T. Heggestad et al.|npj Breast Cancer|2021Cited by 17
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumorsLi Zhu, Adrian V. Lee, Jessica L. Narloch et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 15
Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND StudyTomi Akinyemiju, Adetola Daramola, Taofik Oyekunle et al.|Clinical Breast Cancer|2021Cited by 14